Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,401–1,500 of 2,099
Miš, K., Lulić, A.-M., Marš, T., Pirkmajer, S., & Katalinić, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1139303 · Cited by 5
Exercise in Type 2 Diabetic Peripheral Neuropathy
Fuller, A. A., Singleton, J. R., Smith, A. G., & Marcus, R. L. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0177-6 · Cited by 6
Ovarian cytoarchitectual changes following fennel ingestion in senile diabetic albino rat
Ahmed-Sorour, H., Aal, F. A., & Abdel-Galil, M. (2017) · The Egyptian Journal of Histology · doi:10.21608/ejh.2017.5685 · Cited by 6
“The reduction in body weight that was recorded among senile diabetic rats (GIII) is in agreement with DeFronzo and Tripathy[30] who reported the association between insulin resistance in type 2 diabetes, elevated rates of lipolysis, increased plasma non-esterified fatty acids (NEFAs) and triglyceride concentrations wi…”
BackgroundWhole Egg Consumption Impairs Insulin Sensitivity in a Rat Model of Obesity and Type 2 Diabetes
Saande, C. J., Steffes, M. A., Webb, J. L., Valentine, R. J., Rowling, M. J., & Schalinske, K. L. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz015 · Cited by 5
The vascular endothelium plays a role in insulin action
Kolka, C. M. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13171 · Cited by 7
Kang, S. Y., Hyun, S. Y., Kwon, Y., Park, Y.-K., & Jung, H. W. (2019) · The Korea Journal of Herbology · doi:10.6116/kjh.2019.34.6.99 · Cited by 7
Khan, A., Fouda, S., Mahzari, A., Chan, S. M. H., Zhou, X., Ratnam, C., Vlahos, R., & Ye, J.-M. (2020) · Clinical science · doi:10.1042/cs20200173 · Cited by 4
Shirif, A. Z., Kovačević, S., Brkljačić, J. M., Teofilović, A., Elaković, I., Djordjevic, A. D., & Matić, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137206 · Cited by 7
“Skeletal muscle is the central organ responsible for insulin-regulated glucose uptake and adjustment of whole-body metabolism to energy challenging conditions [5,6].”
BackgroundMechanisms of insulin signal transduction
Langlais, P. R., Mandarino, L. J., & Garvey, W. T. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch12 · Cited by 11
Maina, J. G., Balkhiyarova, Z., Nouwen, A., et al. (2022) · medRxiv · doi:10.1101/2022.12.06.22283143 · Cited by 5
Lim, J. H., Kim, M. H., Han, H.-J., Yang, S. J., Kim, M.-G., Lee, H. J., Han, Y. J., Chung, J. H., Kwak, D. W., Yang, S., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0280 · Cited by 4
“Skeletal muscle plays a crucial role in insulin-mediated glucose uptake after meals and is essential for glycogen synthesis [18].”
Tang, J., Cai, X., Liu, A., Yu, N., & Wang, S. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01579-4 · Cited by 4
“Insulin resistance in skeletal muscle is the main defect in T2DM and is therefore central to systemic insulin resistance and T2DM [23].”
BackgroundThe Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Henriksen, K., Chakravarthy, M. V., Bager, C. L., Larsen, A. T., Mohamed, K. E., & Karsdal, M. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16379 · Cited by 4
“50 Hepatic insulin resistance is a complex phenomenon, involving hepatic lipid accumulation, increased inflammation and regulation of the components of IR-mediated signalling cascades.”
Choi, Y. R., & Kim, M. J. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105198 · Cited by 4
Wan, F., Lian, R., Huang, J., & Jian-ling, D. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03193-3 · Cited by 6
“Skeletal muscle, the largest insulin-sensitive organ, loses mass and function, directly impairing glucose tolerance and promoting diabetes [26].”
Kurinami, N., Sugiyama, S., Yoshida, A., Hieshima, K., Suzuki, T., MIYAMOTO, F., Kajiwara, K., Jinnouchi, K., Ashida, K., Nomura, M., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00670-8 · Cited by 7
“Skeletal muscle is the primary site of glucose uptake, and both the quantity and quality of muscle tissue have a profound effect on insulin responsiveness [24, 25].”
Surapaneni, S., Kerru, N., Bhonsle, R. R., Kapavarapu, R., & Maddila, S. (2025) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2025.144841 · Cited by 4
Katsanos, C. S., Liu, Z., & Atherton, P. J. (2026) · Comprehensive physiology · doi:10.1002/cph4.70126 · Cited by 8
“Skeletal muscle plays a central role in whole-body glucose disposal, accounting for approximately 80% of insulin-stimulated glucose uptake in normal physiology (Thiebaud et al. 1982; DeFronzo and Tripathy 2009).”
Sazdova, I., Gagov, H., Hadzi‐Petrushev, N., Konaktchieva, M. N., Konakchieva, R., & Mladenov, M. I. (2026) · Applied Sciences · doi:10.3390/app16063027 · Cited by 6
Ramos‐Jiménez, A., Rubio-Valles, M., Arvizuo, J. G., Juárez-Oropeza, M. A., Ramos-Hernández, J. A., Chávez-Guevara, I. A., González-Rodríguez, E., Moreno-Brito, V., & Torres, R. P. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083475 · Cited by 7
Li, T., Lv, Q., Liu, C., Li, C., Xie, X., & Zhang, W. (2024) · Molecules · doi:10.3390/molecules29071605 · Cited by 4
“Insulin resistance in skeletal muscles can occur decades before the development of β -cell failure and the onset of type 2 diabetes symptoms [4,7].”
BackgroundLi, H., Li, C.-F., Liu, C., Chen, S., Liu, Y., Lv, Q., & Zhang, W. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04592-1 · Cited by 7
“Since skeletal muscle is the principal site of insulin-stimulated glucose uptake, it is also considered to be the main cause of whole-body insulin resistance [13, 19].”
BackgroundTao, W., Wang, X., Yang, M., Zhou, X., Yin, M., Yang, Y., & Li, Y. (2024) · International Journal of Immunogenetics · doi:10.1111/iji.12698 · Cited by 4
“Insulin resistance is attributedtoimpairedinsulinsignallinginadipocytesandskeletalmus-cles (DeFronzo & Tripathy, 2009; Zatterale et al., 2019).”
Kramer, C. S., Monsegue, A. P., Morwani‐Mangnani, J., Grootswagers, P., Beekman, M., Slagboom, P. E., Verdijk, L. B., & de Groot, C. P. G. M. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.112002 · Cited by 5
“For example, age-related decline of muscle mass, quality and physical activity are thought to be the main drivers of insulin resistance (DeFronzo and Tripathy, 2009; Thiebaud et al., 1982; Srikanthan and Karlamangla, 2011).”
ZBED6 Knockout Prevents Ageing‐ and Dexamethasone‐Induced Muscle Atrophy via Dkk3 in Pig and Mice
Wei, C., Wang, D., Ma, Y., Wang, S., Pan, D., Ma, Y., & Jiang, L. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13829 · Cited by 5
“These adverse effects are partly attributed to the loss of muscle mass, as skeletal muscles are responsible for the majority of postprandial glucose uptake [36].”
Soliman, S. B., Chugh, O. K., Leuteneker, J. E., Tuska, B., Ye, W., Zhang, T., Rode, T., Howton, S. M., Buras, E. D., & Horowitz, J. F. (2025) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16741 · Cited by 4
“7,14,15 7 – 13,16 – 18 Globally, an 22 However, there is currently no simple, noninvasive method available to detect developing insulin resistance.”
Frailty – An emerging high impact complication of diabetes requiring specific management approaches
Sinclair, A. J., & Vellas, B. J. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0868-5 · Cited by 5
“Muscle loss is also accelerated in diabetes (13) and lower limb muscles may be in a profound state of insulin resistance (14).”
Salmi, I. A., & Hannawi, S. (2018) · Integrative Obesity and Diabetes · doi:10.15761/iod.1000214 · Cited by 4
Zafar, U. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_23 · Cited by 5
Sekar, G. (2022) · Bioinformation · doi:10.6026/973206300181098 · Cited by 4
Saxena, G., Gallagher, S., Law, T., Maschari, D., Walsh, E., Dudley, C., Brault, J. J., & Consitt, L. A. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00199.2023 · Cited by 6
Narayanan, N., Sahoo, J., Kamalanathan, S., Sagili, H., Bobby, Z., Naik, D., Roy, A., & Merugu, C. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_7_23 · Cited by 4
“[36] This explains the similar hepatic insulin resistance in the two groups in our study.”
BackgroundResultDiabetes Pharmacotherapy and its effects on the Skeletal Muscle Energy Metabolism
Yu, B., Wang, D., Zhou, J., Huang, R., Cai, T., Hu, Y., Zhou, Y., & Ma, J. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575299439240216081711 · Cited by 5
Burghardt, K. J., Burghardt, P. R., Howlett, B. H., Dass, S. E., Zahn, B., Imam, A. A., Mallisho, A., Msallaty, Z., Seyoum, B., & Yi, Z. (2024) · Biomedicines · doi:10.3390/biomedicines12051057 · Cited by 6
“A primary tissue where insulin resistance develops is within the skeletal muscle [12,13].”
BackgroundFang, L., Kong, F., Ou, K., Hong, L., Wang, C., & Tong, X. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119597 · Cited by 6
Jasim, A. R. M., Abhirami, B. L., Anto, E. M., George, S., Jayamurthy, P., & Kumaran, A. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.07.060 · Cited by 4
Costa, J. S. R., Silva, G., Guimarães, I. C., Silva, L. F. R., da Silva, S. S., Almeida, J. P. D. P., Coimbra, C. C., Parizotto, N. A., Gripp, F., Dias‐Peixoto, M. F., et al. (2024) · Journal of Biophotonics · doi:10.1002/jbio.202400274 · Cited by 5
“As the skeletal muscle is a major site of glucose disposal [98], skeletal muscle hypertrophy is considered to be pivotal to the improvement of insulin resistance [99].”
Causal association between insulin sensitivity index and Alzheimer's disease
Xu, F., Wu, S., Gao, S., Li, X., Huang, C., Chen, Y., Zhu, P., & Liu, G. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16254 · Cited by 4
“This dysregulation of insulin action in the post-prandial state has been identified as one of the key steps in the patho - genesis of T2D (DeFronzo & Tripathy, 2009 ).”
Song, G., Choi, M., Park, W. Y., Kim, S. H., Jiao, W., Park, J. Y., Ahn, K. S., Kwak, H. J., & Um, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1455805 · Cited by 6
Viswanathan, M. P., Mullainadhan, V., & Karundevi, B. (2024) · International Journal of Toxicology · doi:10.1177/10915818241305090 · Cited by 4
“31 Insulin binds to the INSR on the surface of muscle cells, triggering the autophosphorylation of the INSR and activating the signaling cascade necessary for the translocation of GLUT4 protein from the cytosol to the membrane.”
Effects of antidiabetic agents on lipid metabolism of skeletal muscle: A narrative review
Xu, M., Lv, D., Wei, H., Li, Z., Jin, S., Liu, Q., Zhang, Y., & Liu, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16189 · Cited by 5
“21 Consequently, skeletal muscle metabolism not only plays an integral role in maintaining whole-body energy equilibrium but also participates in metabolic disorders, such as insulin resistance and glucose intolerance.”
Katare, P. B., Tingstad, R. H., Beajani, S., Indseth, J. P., Telle‐Hansen, V. H., Myhrstad, M. C. W., Rustan, A. C., Eide, L., Witczak, O., & Aas, V. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100764 · Cited by 4
“Skeletal muscle is a major organ for oxidation of fatty acids and carbohydrates and contributes significantly to peripheral insulin resistance in type 2 diabetes (22); therefore, it is important to understand the effect of BCFAs on skeletal muscle.”
Cao, Y., Tang, M., Zhao, J., & Yin, L. (2025) · BMC Public Health · doi:10.1186/s12889-025-22149-w · Cited by 6
Secreted EMC10 inhibits muscle GLUT4 activity and glucose uptake in mice
Jin, S., Wu, W., Liu, S., Wang, Y., Huang, Q., He, K., Ni, Y., Chen, K., Huang, J., Liu, L., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110296 · Cited by 4
“In the context of type 2 diabetes, insulin-stimulated glucose disposal of skeletal muscle is reduced by 50%, highlighting the importance of skeletal muscle in the pathogenesis of type 2 diabetes (2).”
Zheng, S., Shao, L., Zhu, J., Sun, J., Chen, Z., Cao, X., Zhang, C., Xia, T., & Shen, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-95344-9 · Cited by 6
“Previous studies have indicated that skeletal insulin resistance is a significant link between sarcopenia and glucose abnormalities 42 .”
Hamed, A. M., Seif-Eldein, N. A., Thabet, S. A., Osman, A., Refaei, R. A., Hamed, A., Abouelella, A., El-Tantawy, W. H., Temraz, A., & Wafa, S. A. A. E. (2025) · Scientific Reports · doi:10.1038/s41598-025-02340-0 · Cited by 6
“Insulin resistance in skeletal muscle is recognized as the principal problem, frequently emerging decades prior to the development of β-cell failure and notable hyperglycemia 26,27 .”
Yang, X. P., Lai, P., Chen, X., Liu, Z., Yuan-mou, T., Rao, S., Wen, C., Shi-rong, J., & Ji, L. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400421 · Cited by 4
Role of Exercise on Inflammation and Chronic Disease
Buresh, R. J., & Berg, K. E. (2014) · Strength and conditioning journal · doi:10.1519/ssc.0000000000000071 · Cited by 6
“Muscle tissue is important in this regard as it accounts collectively for 75–80% of insulin-mediated glucose disposal (8).”
BackgroundNeto, J. G. O., Bento‐Bernardes, T., Pazos-Moura, C. C., & Oliveira, K. J. (2018) · Endocrine · doi:10.1007/s12020-018-1775-1 · Cited by 4
Osteosarcopenia as a Lipotoxic Disease
Saedi, A. A., Goodman, C. A., Myers, D. E., Hayes, A., & Duque, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-25890-0_6 · Cited by 5
Amadi, J. A., Amadi, P. U., Njoku, U. C., & Onitchi, C. L. (2021) · PubMed Central · doi:10.22038/ijbms.2020.49770.11368 · Cited by 6
“Though, several factors contribute to the onset and aggravation of insulin resistance, numerous studies have implicated the loss of function of insulin receptor substrates (IRS) as the mechanistic link to the dysregulation of insulin signaling (9-11).”
BackgroundWang, C., Wang, C., Ren, L., Chen, S., Chen, W., & Li, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119037 · Cited by 5
Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptor
Zhu, C., Xu, Z., Yuan, Y., Wang, T., Xu, C., Yin, C., Xie, P., Xu, P., Ye, H., Patel, N., et al. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.253 · Cited by 5
Alkhateeb, H. H., & Al‐Duais, M. (2022) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2022.24 · Cited by 5
“Impairing GLUT4 translocation in the skeletal muscle is widely accepted as an insulin resistance mechanism, resulting in the consequent defect in insulinstimulated glucose uptake (20).”
BackgroundMohapatra, S., Ramachandran, M., Behera, K. K., Priyadarsini, N., Nanda, P., & Devi, S. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.03.010 · Cited by 9
Arad, A. D., DiMenna, F. J., Kittrell, H. D., Kissileff, H. R., & Albu, J. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2022 · Cited by 4
Ferreira, P. P. R., Silva, L. F. R., Dias‐Peixoto, M. F., Cassilhas, R. C., Gripp, F., Amorim, F. T., Mang, Z. A., Esteves, E. A., Tricoli, V., Ferraresi, C., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100984 · Cited by 4
Sulis, P. M., Mendes, A. K. B., Fernandes, T. A., Frederico, M. J. S., Rey, D. P., Aragón, D. M., Ruparelia, K. C., & Silva, F. R. M. B. (2023) · Biochimie · doi:10.1016/j.biochi.2023.04.006 · Cited by 6
PICK1-Deficient Mice Maintain Their Glucose Tolerance During Diet-Induced Obesity
Backe, M. B., Andersen, R. C., Jensen, M. G., Jin, C., Hundahl, C., Dmytriyeva, O., Treebak, J. T., Hansen, J. B., Gerhart‐Hines, Z., Madsen, K. L., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad057 · Cited by 3
“To investigate whether resistance to deterioration could be caused by other peripheral tissues, we looked at the skeletal muscles, as they are the major site for insulin-mediated glucose uptake [35].”
BackgroundPánico, P., Velasco, M., Salazar, A. M., Ostrosky‐Wegman, P., & Hiriart, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165415 · Cited by 5
Chen, D.-S., Zhu, Y.-Q., Ni, W.-J., Li, Y., Yin, G., Shao, Z.-Y., & Zhu, J. (2023) · PeerJ · doi:10.7717/peerj.15761 · Cited by 5
Arsenic disrupts extracellular vesicle-mediated signaling in regenerating myofibers
Clemens, Z. J., Wang, K., Ambrosio, F., & Barchowsky, A. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad075 · Cited by 6
Effect of Root of Atractylodes macrocephala Koidzumi on Myogenesis in C2C12 Cells
Song, M.-Y. (2015) · Journal of Korean Medicine for Obesity Research · doi:10.15429/jkomor.2015.15.1.38 · Cited by 4
Wang, Y., La, X., Tian, C., Dong, Y., Feng, Q., Qiu, C., Gao, X., & Li, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7092140 · Cited by 4
“Insulin resistance in skeletal muscle IR is the initiating and primary defect in T2DM [26, 27].”
BackgroundSarcopenia in patients with diabetes mellitus
Dionyssiotis, Y., Athanassiou, P., Papathanasiou, J. V., EFSTATHOPOULOS, E. P., Prokopidis, K., Trovas, G., & Kostoglou‐Athanassiou, I. (2022) · Folia Medica · doi:10.3897/folmed.64.e63530 · Cited by 5
“Hyperglycemia is a metabolic dysfunction, which may potentially damage muscle cells.[8] Insulin deficiency leads to substantial muscle catabolism.”
BackgroundHolness, M. J., Sugden, P. H., Silvestre, M. P., & Sugden, M. C. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.9 · Cited by 4
Diabetes and Physical Activity
Banu, J. (2016) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/3/1/00140 · Cited by 4
Kang, B., & Chiang, B. (2018) · Food Bioscience · doi:10.1016/j.fbio.2018.12.001 · Cited by 4
Skeletal Muscle Metabolomics for Metabolic Phenotyping and Biomarker Discovery
Dyar, K. A., Artati, A., Cecil, A., & Adamski, J. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9802-9_10 · Cited by 5
Rationale for the use of metformin and exercise to counteract statin‐associated side effects
Haxhi, J., & Thompson, P. D. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13900 · Cited by 4
Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria InteractionsPreprint
Pinelis, I., & Pinelis, V. G. (2021) · Preprints.org · doi:10.20944/preprints202103.0401.v1 · Cited by 3
Moon, S. J., Hu, Y., Dzieciątkowska, M., Kim, A., Chen, P.-L., Asara, J. M., D’Alessandro, A., & Perrimon, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.24.591006 · Cited by 3
The Interaction of Duchenne Muscular Dystrophy and Insulin Resistance
Krishna, S., Quindry, J. C., Valentine, R. J., & Selsby, J. T. (2023) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000328 · Cited by 5
“In all individuals, insulin resistance may be caused by alterations to the signaling cascade, including insulin receptor defects, phosphorylation defects in intermediate steps, and/or defective GLUT4 translocation (45).”
BackgroundTang, C., Lin, P., Zhao, Y., et al. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s448026 · Cited by 3
Ozemek, C., & Hardwick, J. (2025) · Heart and Mind · doi:10.4103/hm.hm-d-24-00078 · Cited by 4
Lee, J.-H., Jung, I., Tu‐Sekine, B., Jin, S., Anokye‐Danso, F., Ahima, R. S., & Kim, S. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062395 · Cited by 5
Frailty, genetic predisposition, and incident chronic kidney disease
Zou, S., Sun, Y. B., Zhou, Y., Yu, B., Li, J., Yu, Y., Chen, J., Li, Y., Wang, N., & Wang, L. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-97280-0 · Cited by 6
“A probable explanation is that handgrip strength and walking pace are key in the diagnosis of sarcopenia, with an associated inverse relationship between muscle mass and insulin resistance 30,31 .”
Larsen, A. T., Melander, S. A., Mohamed, K. E., Petersen, E. A., Benmarce, M., Karsdal, M. A., & Henriksen, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118388 · Cited by 3
Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia
Yiğit, Ş., Ekşi, B. Ü., Satman, İ., Dayıcan, D. K., Çalıkoğlu, F., Sahin, H. R., Perone, F., & Akıncı, B. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02701-8 · Cited by 8
“Previous studies have demonstrated that reduced skeletal muscle mass or quality is associated with adverse metabolic profiles, including insulin resistance, dyslipidemia, and increased cardiovascular risk [6, 15–17].”
Wang, R., Cao, L., Zhang, P., Chen, H., Zhong, Q., Sang, Z., Wu, C., & He, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02744-x · Cited by 5
“Obesity is frequently accompanied by reduced muscle mass, and reductions in appen-dicular skeletal muscle mass (ASM) have been linked to metabolic dysfunction [16, 17].”
Xie, B., Zhu, D., Li, L., Lou, R., Wang, R., Min, J., Yang, Y., Ma, X., & Lin, L. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157444 · Cited by 3
Can Dietary Supplements Support Muscle Function and Physical Activity? A Narrative Review
Brough, L., Rees, G., Drummond‐Clarke, L., McCallum, J. E., Taylor, E., Kozhevnikov, O., & Walker, S. (2025) · Nutrients · doi:10.3390/nu17213495 · Cited by 5
“Skeletal muscle insulin resistance is a major characteristic of obesity and the development of type 2 diabetes [149].”
Zheng, Z., Qing, H., Zhang, L., & Duan, C. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1712376 · Cited by 5
“The physiological mechanisms underlying these associations include improved insulin sensitivity, enhanced metabolic rate, and reduced systemic inflammation, mediated by increased muscle mass and strength (15, 18).”
Underexplored terrain: effects of high priority environmental toxicants on skeletal muscle
Clemens, Z. J., Weaver, L., Brown, A., Kosaraju, J., Barchowsky, A., Miljkovic, I., & Sahu, A. (2025) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2025.2593824 · Cited by 5
“While some temporal relationships have clearly been established, such as skeletal muscle insulin resistance preceding the onset of diabetes (DeFronzo and Tripathy 2009), causal relationships between other muscle-related comorbidities warrant further investigation.”
Fang, Y., Huang, S., Zhang, H., Li, M., Zhang, H., Yang, W., & Yu, M. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03031-w · Cited by 4
Qi, H., Zhang, Z., Hou, T., Ding, L., Liu, Q., Wang, Y., Song, S., Liu, J., Sun, C., Sun, Y., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157750 · Cited by 4
Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
Verhoog, N. J. D., Africander, D., & Storbeck, K. (2026) · Diabetologia · doi:10.1007/s00125-025-06647-5 · Cited by 8
“As skeletal muscle is the largest site for glucose uptake and metabolism [178], postmenopausal E2 loss reduces muscle mass and disrupts energy metabolism, possibly contributing significantly to hyperglycaemia and increased risk of developing type 2 diabetes.”
Azócar-Gallardo, J., Ramírez‐Campillo, R., Afonso, J. R., Sá, M., Granacher, U., González-Rojas, L., Ojeda-Aravena, A., & García‐García, J. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114331 · Cited by 4
“The importance of skeletal muscle lies in the fact that it is responsible for more than 80% of insulin-stimulated glucose uptake [52].”
BackgroundSambashivaiah, S., Bhadra, R., Bhattacharya, S., & Kurpad, A. V. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00349-2 · Cited by 3
Zhao, Q., Zhang, Z., Li, S., & Liu, M. R. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s479900 · Cited by 4
“22,23 Furthermore, patients with T2D often have low muscle mass, which may further increase the risk of metabolic and functional decline.”
BackgroundGaugel, J., Jähnert, M., Neumann, A., Heyd, F., Schürmann, A., & Vogel, H. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109837 · Cited by 6
Linking Circulating Irisin and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Aminov, E., Folan, P., & Pisconti, A. (2025) · JCSM Communications · doi:10.1002/rco2.70000 · Cited by 7
“It has been postulated that insulin resistance in skeletal muscle may be the initial cause of increased insulin secretion by β-cells [20–23].”
Montgomery, M. K., Lin, S., Yang, C.-H., Prasad, K., Cheng, Z. J., Bayliss, J. A., Leeming, M. G., Williamson, N. A., Loh, K., Dong, L., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06413-7 · Cited by 5
“Furthermore, despite skeletal muscle accounting for 80% of insulin-stimulated glucose disposal [2], and being the primary site of insulin resistance in individuals with type 2 diabetes [3], current therapies do not directly target muscle glucose disposal for therapeutic gain.”
Sevilla-González, M. D. R., Hanson, P. A., Islam, J., Hsu, S. C., Tsoukas, M. A., Marliss, E. B., Reiner, A. P., Gravel, M., Kooperberg, C. L., Clish, C. B., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf454 · Cited by 3
Miranda-Ferrúa, E., Cadenas‐Sánchez, C., Medrano, M., Ruiz, J. R., Idoate, F., Osés, M., Alavarez, M. C., Cabeza, R., & Labayen, I. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01903-5 · Cited by 3
“Our study conducted in two cohorts of children predominantly presenting overweight or obesity, reinforces this concept with robust data, utilizing MRI to measure skeletal muscle mass and quality.”
Levy, Y. A., Ciaraldi, T. P., & Henry, R. R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06104-z · Cited by 4
Sretenovic, D. B., Veselinovc, M., Turnić, T. N., Azanjac, A., Koricanac, A., & Lucic, A. T. (2021) · Vojnosanitetski pregled · doi:10.2298/vsp210216041b · Cited by 3
Bengtsen, M. B., Hansen, E. S. S., Tougaard, R. S., Lyhne, M. D., Rittig, N. F., Støy, J., Jessen, N., Mariager, C. Ø., Stødkilde‐Jørgensen, H., Møller, N., et al. (2021) · Experimental Physiology · doi:10.1113/ep089782 · Cited by 2
Chien, H., Constantin, D., Greenhaff, P. L., & Constantin‐Teodosiu, D. (2021) · Biology · doi:10.3390/biology10111098 · Cited by 3
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.